Cleared Traditional

K221321 - MAC 5 A4/ MAC 5 A5/ MAC 5 Lite Resting ECG Analysis System
(FDA 510(k) Clearance)

Oct 2022
Decision
165d
Days
Class 2
Risk

K221321 is an FDA 510(k) clearance for the MAC 5 A4/ MAC 5 A5/ MAC 5 Lite Resting ECG Analysis System. This device is classified as a Electrocardiograph (Class II - Special Controls, product code DPS).

Submitted by Ge Medical Systems Information Technologies, Inc. (Wauwatosa, US). The FDA issued a Cleared decision on October 18, 2022, 165 days after receiving the submission on May 6, 2022.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2340.

Submission Details

510(k) Number K221321 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 06, 2022
Decision Date October 18, 2022
Days to Decision 165 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DPS — Electrocardiograph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2340